Cohance Lifesciences Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 2,52,579 shares,. Its Average Traded Price (ATP) is ₹458.15, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹457.60.
Cohance Lifesciences has an upper circuit limit of ₹550.30 and a lower circuit limit of ₹366.90. The total value traded stands at ₹11.57 CR, and the delivery percentage for the day is 33.86%.
The stock is currently traded with a market lot size of 1. Cohance Lifesciences also offers a dividend yield of 0%.
Cohance Lifesciences Share Price Chart
Cohance Lifesciences Share Key Metrics
Volume
2.53 L
Market Cap
17507.65 CR
LTQ@LTP
5@457.60
ATP
458.15
Var Margin
22 %
Circuit Range
366.9-550.3
Delivery %
33.86 %
Value
11.57 CR
ASM/GSM
No
Market Lot
1
Cohance Lifesciences Resistance and Support
Pivot 463.22
Resistance
First Resistance
471.29
Second Resistance
483.97
Third Resistance
492.04
Support
First Support
450.54
Second Support
442.47
Third Support
429.79
Cohance Lifesciences Shareholding Pattern
View More- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-06 | Quarterly Results |
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasti Property and Equity Holdings transferred a 1.33% stake (51 lakh shares) to Jasub Property Holdings LLP via an inter-se block deal on November 9 and 11. The total group holding remains unchanged at 6.36%.
Nov 11 2026 19:19:13
Cohance Lifesciences Ltd - 543064 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasub Property Holdings LLP acquired 51 lakh shares (1.33% stake) in Cohance Lifesciences from Jasti Property and Equity Holdings via block deals. The transaction is an inter-se transfer, keeping the total PAC group shareholding unchanged at 6.36%.
Nov 11 2026 19:17:41
Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Jasub Property Holdings acquired 51 lakh shares (1.33%) from Jasti Property via an inter-se transfer. The total shareholding of the group in Cohance Lifesciences remains unchanged at 6.36%.
Nov 11 2026 16:42:35
Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Cohance Lifesciences reported an inter-se transfer of 51 lakh shares (1.33% stake) from Jasti Property to Jasub Property Holdings. The transaction was executed via block deals, with the total group holding remaining unchanged at 6.36%.
Nov 11 2026 16:41:19
Cohance Lifesciences Ltd - 543064 - Update On USFDA Inspection For Company'S Pashamylaram Manufacturing Facility
Cohance Lifesciences announced that the USFDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility in Pashamylaram, Hyderabad. The inspection outcome has been classified as Voluntary Action Indicated (VAI), marking the conclusion of the inspection.
Nov 07 2026 11:11:27
Cohance Lifesciences Ltd - 543064 - General Announcement
Cohance Lifesciences has been directed by the Telangana State Pollution Control Board to suspend manufacturing at its Suryapet site immediately. The order follows an industrial accident that resulted in an employee's death and alleged non-compliance with safety measures.
Nov 06 2026 08:22:23
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Alembic Pharmaceuticals Ltd.
1057.10
26.95 (2.62%)
Shilpa Medicare Ltd.
938.35
-53.15 (5.36%)
Astrazeneca Pharma India Ltd.
6033.00
1.50 (0.02%)
Onesource Specialty Pharma Ltd.
1612.70
2.60 (0.16%)
Caplin Point Laboratories Ltd.
2346.80
-41.90 (1.75%)
Eris Lifesciences Ltd.
1329.70
22.50 (1.72%)
Pfizer Ltd.
3818.30
-29.10 (0.76%)
Dr. Agarwal's Health Care Ltd.
550.70
-0.10 (0.02%)
Poly Medicure Ltd.
1684.30
3.10 (0.18%)
Molbio Diagnostics Ltd.
1486.40
-6.80 (0.46%)
Cohance Lifesciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in COHANCE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC